仑伐替尼联合TACE辅助治疗术后高复发风险肝细胞癌患者：LANCE研究结果更新
评价者：张必翔1, 文献合成者：邹威2

Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse： Updated of LANCE Study
Reviewer: ZHANG Bi-xiang1, Literature Co-worker: ZOU Wei2